Shows / Conversations in Lung Cancer Research
Conversations in Lung Cancer Research
Welcome to Conversations in Lung Cancer Research, presented by TOGA, your go-to podcast for in-depth insights into lung cancer. Tune in for conversations with leading experts, inspiring stories, and the latest updates on clinical trials. Stay informed and empowered in the fight against lung cancer.
Episodes
Conversations in Lung Cancer ResearchThe Evolving Role of Radiation Oncology in Lung Cancer Management
In this episode of TOGA's Conversations in Lung Cancer Research, host Prof. Shalini Vinod (Radiation Oncologist, Liverpool Hospital, Sydney) and guests Dr…
Conversations in Lung Cancer ResearchBispecific Antibodies in Thoracic Oncology
In this episode of TOGA's Conversations in Lung Cancer Research, host Dr. Samantha Bowyer (Sir Charles Gairdner Hospital, Perth), alongside A/Prof Rachel…
Conversations in Lung Cancer ResearchTargeting VEGF in Thoracic Oncology
In this episode of Conversations in Lung Cancer Research, host A/Prof Prunella Blinman (Medical Oncologist from Concord Hospital, Sydney) is joined by…
Conversations in Lung Cancer ResearchThe Evolving Landscape of ROS1-positive NSCLC
In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Steven Kao, Medical Oncologist at Chris O'Brien Lifehouse, is joined by A/Prof…
Conversations in Lung Cancer ResearchProf Zarnie Lwin OAM: Mentorship, Research, and the Future of Lung Cancer Treatment
In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Mel Moore welcomes Prof Zarnie Lwin OAM (University of Queensland; Medical…
Conversations in Lung Cancer ResearchSmoking Stigma and Lung Cancer Care in the Screening Era
In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Gavin Wright sits down with a multidisciplinary panel of experts to tackle the…
Conversations in Lung Cancer ResearchDr. Jazmin Eckhaus: Robotic Innovations and Ethics in Thoracic Surgery
In this episode of 'Conversations in Lung Cancer Research,' host A/Prof Mel Moore interviews Dr. Jazmin Eckhaus, a practising surgeon in the subspecialty of…
Conversations in Lung Cancer ResearchImmunotherapy in Thoracic Cancers: Applying Broad IO Access Across Thoracic Malignancies
In this second part of TOGA's Conversations in Lung Cancer Research two-episode series, A/Prof Adnan Nagrial, a Medical Oncologist at Westmead Hospital, leads…
Conversations in Lung Cancer ResearchImmunotherapy in Thoracic Cancers: From Indication-Based to Biology-Driven
In this first part of a special two-episode series of TOGA's Conversations in Lung Cancer Research podcast, A/Prof Deme Karikios, a Medical Oncologist at the…
Conversations in Lung Cancer ResearchThe Evolving Landscape of BRAF-Mutated NSCLC in Australia
In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Rachel Roberts-Thomson, a Medical Oncologist at The Queen Elizabeth Hospital and…
Conversations in Lung Cancer ResearchThymic Cancer: The Lesser-Known Thoracic Tumours
In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Malinda Itchins, a medical oncologist and clinician researcher at Royal North…
Conversations in Lung Cancer ResearchA/Prof Surein Arulananda: A Masterclass in Career Growth
In this episode of TOGA's 'Conversations in Lung Cancer Research,' A/Prof Mel Moore interviews A/Prof Surein Arulananda, the interim Director of Medical…
Conversations in Lung Cancer ResearchTOGA ASM 2026: Program Review
In this episode of 'Conversations in Lung Cancer Research,' host A/Prof Surein Arulananda (Medical Oncologist, Monash Health) is joined by members of the Local…
Conversations in Lung Cancer ResearchALK TKI Sequencing in the Australian Landscape
In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Tim Clay sits down with Australian oncology luminaries Prof Ben Solomon and A/Prof…
Conversations in Lung Cancer ResearchProfessor Michael Millward: Clinical Insights in Lung Cancer Research
In this episode of 'Conversations in Lung Cancer Research,' A/Prof Mel Moore talks with Prof Michael Millward, Foundation Professor of Clinical Cancer Research…
Conversations in Lung Cancer ResearchDr. Megan Sanders: From Science to TOGA Leadership
In this episode of Conversations in Lung Cancer Research, host A/Prof Mel Moore interviews Dr. Megan Sanders, the Chief Executive Officer of TOGA. They discuss…
Conversations in Lung Cancer ResearchLung Cancer Research: 2025 Year in Review
In this episode of 'Conversations in Lung Cancer Research,' hosted by Associate Professor Mal Itchens, a multidisciplinary panel delves into the ongoing…
Conversations in Lung Cancer ResearchNew and Emerging Practice Standards in ES-SCLC
In this episode of 'Conversations in Lung Cancer Research,' host Dr. Rebecca Tay and fellow oncologists A/Prof Surein Arulananda and Dr. Dasantha Jayamanne…
Conversations in Lung Cancer ResearchExploring Lung Cancer Care and Research in New Zealand
In this episode of 'Conversations in Lung Cancer Research' hosted by Dr Alex Davis, features a discussion with Dr. Laird Cameron and Dr. Annie Wong on the…
Conversations in Lung Cancer ResearchChallenging Ageism: Optimising Lung Cancer Treatment in Older Adults
In this episode of Conversations in Lung Cancer Research, hosted by Dr Michael Krasovitsky, a medical oncologist at St. Vincent's Hospital in Sydney, the focus…
Conversations in Lung Cancer ResearchProf. Anna Nowak: A Journey from Oncology Lab to Leadership
In this episode of Conversations in Lung Cancer Research, host A/Prof Mel Moore interviews Prof Anna Nowak, a renowned medical oncologist, clinical trialist…
Conversations in Lung Cancer ResearchCNS Progression in Lung Cancer: A Practical Conversation on Best Practices
n this episode of Conversations in Lung Cancer Research, A/Prof Tim Clay discusses the multidisciplinary management of CNS metastases in the context of…
Conversations in Lung Cancer ResearchA/Prof Fiona Hegi Johnson: Navigating Careers and Innovations in Lung Cancer Research
In this episode of 'Conversations in Lung Cancer Research,' A/Prof Mel Moore sits down with A/Prof Fiona Hegi Johnson, a radiation oncologist at the Peter…
Conversations in Lung Cancer ResearchProf Shankar Siva: Pushing Boundaries in Radiation Oncology
In this episode of TOGA's Conversations in Lung Cancer Research, A/Prof Mel Moore speaks with Prof Shankar Siva about his groundbreaking work in radiation…
Conversations in Lung Cancer ResearchThe Emerging Role of the Microbiome in Lung Cancer and Immunotherapy Response
This episode of 'Conversations in Lung Cancer Research' features Dr. Anna McLean, Dr Mark Adams, and Dr Sagun Parakh, discussing research on the microbiome and…
Conversations in Lung Cancer ResearchLessons from Fellowships and building Clinical Trials Units
In this episode of Conversations in Lung Cancer Research, we welcome A/Prof Bryan Chan, a senior Medical Oncologist and this years TOGA ASM Convener. Bryan…
Conversations in Lung Cancer ResearchProf Wendy Cooper: Journey of a Thoracic Pathologist
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore speaks with Prof Wendy Cooper, a leading pathologist in cancer research. They…
Conversations in Lung Cancer ResearchVaccines in Thoracic Oncology: The Next Frontier in Immunotherapy
In this episode of 'Conversations in Lung Cancer Research,' Professor Tom John from the Peter MacCallum Cancer Centre in Melbourne discusses the significant…
Conversations in Lung Cancer ResearchThe Role of Liquid Biopsy in Modern Oncology
In this episode of Conversations in Lung Cancer Research, Dr. Malinda Itchins, Dr. Annie Wong, and A/Prof Stephen Kao discuss the concept of liquid biopsy, its…
Conversations in Lung Cancer ResearchExploring EGFR Exon 20 Insertion Mutations
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore, along with thoracic oncologists Dr. Malinda Itchins and A/Prof Surein Arulananda…
Conversations in Lung Cancer ResearchFrom Clinical Research to Leadership: A Conversation with Prof. Michael Boyer
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore interviews Prof Michael Boyer, AM about his extensive career in medical oncology and…
- Conversations in Lung Cancer Research
Introducing Conversations in Lung Cancer Research - Trailer
In this introductory episode, Associate Professor Mel Moore, medical oncologist and education chair at TOGA, announces the evolution of TOGA podcasts to…
Conversations in Lung Cancer ResearchNavigating Resistance in ALK-Positive NSCLC Patients on TKI Therapy
We have witnessed incredible advances in therapy since ALK was discovered in 2007, starting from the pivotal PROFILE 1001 study of crizotinib in advanced ALK…
Conversations in Lung Cancer ResearchHit It With Your Best Shot- The Case for IO in Early-Stage NSCLC in a Once in a Lifetime World
Editor's Note (June 2026): This episode was recorded prior to Australia's broad PBS listing of nivolumab and ipilimumab, which has removed the previous "once…
Conversations in Lung Cancer ResearchLarge-Cell Neuroendocrine Carcinoma of the Lung (LCNEC): Challenges in Diagnosis and Treatment
In this episode, we discuss the clinical and diagnostic markers when identifying a rare sub type of NSCLC, large-cell neuroendocrine carcinomas (LC-NEC), and…
Conversations in Lung Cancer ResearchManagement of Limited-Stage Small Cell Lung Cancer (LS-SCLC)
--------------- Support TOGA Thank you for listening to Conversations in Lung Cancer Research. If you enjoyed this episode, please rate and review us on Apple…
Conversations in Lung Cancer ResearchNTRK1, 2,3 And Other Rare Mutations In NSCLC
In this TOGA podcast, we provide an overview of the treatment options for rare subtypes of oncogene driven NSCLC that are now readily identified in the…
Conversations in Lung Cancer ResearchDecoding Perioperative Immunotherapy In NSCLC
In this TOGA podcast, we provide an overview of the recent neoadjuvant, adjuvant, and perioperative IO data, the options and considerations for treatment and…
Conversations in Lung Cancer ResearchAccess to New Medicines: Which Surrogate Endpoints Matter
Do we need to evolve the bar on evidence required for drug reimbursement? The gold standard endpoint for assessing the benefit of anti-cancer drugs has been…
Conversations in Lung Cancer ResearchLung Cancer Nurses: Essential, Beneficial and a Key Link In Lung Cancer Screening
Lung Cancer Support Nurse - Lung Foundation Australia Quit Centre | Homepage Lung Cancer Screening Program: Early Detection Saves Lives…
Conversations in Lung Cancer ResearchUnderutilisation of Radiotherapy in Lung Cancer Treatment
Radiation therapy can be a very effective treatment for lung cancers, with 77% of patients indicating for radiation therapy in their disease trajectory. Yet…
Conversations in Lung Cancer ResearchRevolutionising Lung Cancer Healthcare with AI: Unlocking the Future
Artificial intelligence (AI) is transforming medicine. Lung Cancer healthcare professionals are interested in the use of AI in radiology, particularly in early…
Conversations in Lung Cancer ResearchAntibody Drug Conjugates (ADCs) – An Emerging Treatment Platform in Lung Cancer
In this TOGA Podcast the speakers discuss Antibody Drug Conjugates (ADCs) – An Emerging Treatment Platform in Lung Cancer. The discussion explores the…
Conversations in Lung Cancer ResearchLung cancer Screening and Moving from Concept to Roll Out
This TOGA Podcast discusses Lung cancer Screening and Moving from Concept to Roll Out. The conversation explores the International Lung Cancer Screening Trial…
Conversations in Lung Cancer ResearchEarly Recovery After Surgery - Guidelines and Multidisciplinary Considerations
This TOGA Podcast discusses strategies for enhancing patients’ recovery from lung cancer resection in light of new and emerging data for new peri-operative…
Conversations in Lung Cancer ResearchNature and nurture: lung cancer risk and implications for future screening
This TOGA Podcast discusses the data surrounding air pollution and lung cancer. The discussion delves into Nature and nurture and lung cancer risk and…
Conversations in Lung Cancer ResearchOperability in Stage III NSCLC
In this TOGA Podcast, we discuss what defines operability in locally advanced stage III NSCLC. A/Professor Tim Clay, Medical Oncologist from St John of God…
Conversations in Lung Cancer ResearchNSCLC and KRAS Mutations
In this TOGA Podcast, Australian medical oncologist, Associate Professor Chee Lee, St George Hospital, Kogarah, is joined by medical oncologist Dr Tristan…
Conversations in Lung Cancer ResearchTreatment Considerations in ALK-Positive NSCLC
In this TOGA Podcast, Australian medical oncologist Dr Jenny Lee at Chris O’Brien Lifehouse, Sydney, is joined by medical oncologist Professor Nick Pavlakis…
Conversations in Lung Cancer ResearchCelebrating Female Leadership in Medical Research
In this TOGA Podcast, and on International Women’s Day 2023, we celebrate female leadership in medical research. We explore the challenges and success pathways…
Conversations in Lung Cancer ResearchBrain metastases in NSCLC
Recent studies in NSCLC patients with ALK or EGFR mutations and brain metastases, demonstrated greater benefit from the use of specific targeted therapies. In…
Conversations in Lung Cancer ResearchNGS panels in lung cancer
In this Podcast, Dr Malinda Itchins, Medical Oncologist at Royal North Shore Hospital, Co-Chair of the Advanced Non-Small Cell Lung Cancer Group for TOGA and…
Conversations in Lung Cancer ResearchLung Cancer Screening and its impact on patient care in Australia
In the latest TOGA Podcast, Gavin Wright discusses Lung Cancer Screening and its impact on patient care in Australia, accessibility and practicalities of the…
Conversations in Lung Cancer ResearchThe Management of Stage III NSCLC
Welcome to the Thoracic Oncology Group of Australasia Podcast series. Associate Professor Shankar Siva, Radiation Oncologist and current Cancer Council…
Conversations in Lung Cancer ResearchThe Changing Course of Outcomes in Early Stage NSCLC: Surgical and Respiratory Medicine Considerations
Welcome to the Thoracic Oncology Group of Australasia Podcast series. In this Podcast, we discuss early NSCLC management and treatment, particularly in light…
Conversations in Lung Cancer ResearchCardiotoxicity and Radiation Therapy - Considerations for Lung Cancer
For lung cancer patients, the benefits of treatment and potential for cure must always be balanced with risk. Cardiotoxicity is considered a short and long…
Conversations in Lung Cancer ResearchAccelerating Progress in Oncogene-driven Lung Cancer
Deme Karikios, Medical Oncologist and Director of Clinical trials at Nepean Cancer Care Centre in Sydney is joined by Wanda Cui, Medical Oncologist from the…
Conversations in Lung Cancer ResearchAccess to Molecular Diagnostics and Treatments Across ANZ: The Past, Present, Future
The identification of molecular subtypes of non-squamous NSCLC continues to grow, spurring the development of targeted therapies designed to target these…
Conversations in Lung Cancer ResearchPractical smoking cessation advice for health care providers
In this TOGA Podcast, we discuss smoking cessation in the face of smoking-related stigma and nihilism. Dr Henry Marshall, Associate Professor and Clinical…
Conversations in Lung Cancer ResearchConsider Every Trial as a TeleTrial
Barriers and facilitators and a unique insight into the patient benefits are discussed between Alexandra, patient advocate, teletrials participant and lung…